BUZZ-Australia's Immuron hits near 1-month high on US Defense-funded research
Reuters
Dec 03, 2025
BUZZ-Australia's Immuron hits near 1-month high on US Defense-funded research
** Shares of Australia's Immuron IMC.AX rise as much as 12.1% to A$0.074, their highest since November 5
** Biopharmaceutical firm announces new research agreement with the Naval Medical Research Command and the Walter Reed Army Institute of Research in Silver Spring, U.S., funded by U.S. Department of Defense
** Immuron is collaborating to progress to develop two new oral therapeutics targeting Campylobacter and Shigella, bacteria that cause diarrhea diseases
** IMC, YTD down 11.4%
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.